Summation: β-lactam resistance surveillance in the Asia-Western Pacific Region

Diagnostic Microbiology and Infectious Disease

Volumn 35, Issue 4, 1999, Pages 333-338

  Jones, Ronald N ^a  

^a Diagn Microbiol Infect Dis U   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; IMIPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON;

ANTIBIOTIC RESISTANCE; ASIA; CONFERENCE PAPER; ENTEROBACTER; ENZYME ACTIVITY; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; IN VITRO STUDY; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; STAPHYLOCOCCUS; TECHNIQUE;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, MICROBIAL; ENTEROBACTER; HUMANS; MICROBIAL SENSITIVITY TESTS; OXACILLIN; PSEUDOMONAS AERUGINOSA;

EID: 0033374135     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00110-8     Document Type: Conference Paper

References (25)

1. Barradell L.B., Bryson H.M. Cefepime a review of its antibacterial activity, pharmacokinetic properties and therapeutic use . Drugs. 47:1994;471-505.
2. Bolmstrom A, Arvidson S, Ericson M, Karlsson A (1988). A novel technique for direct quantification of antimicrobial susceptibility of microorganisms (Abst 1208). Interscience Conference Antimicrobial Agents and Chemotherapy, Los Angeles, CA 1994. Washington, DC: American Society for Microbiology.
3. Brown D.F.J., Brown L. Evaluation of the Etest a novel method of quantifying antimicrobial activity . J Antimicrob Chemother. 27:1991;185-190.
4. Jones R.N., Salazar J.C., Pfaller M.A., Doern G.V. Multi-center evaluation of the antimicrobial activity for six broad-spectrum β-lactams in Colombia using the Etest method. Diagn Microbiol Infect Dis. 29:1997;265-272.
5. Lewis M.T., Biedenbach D.J., Jones R.N. In vitro evaluation of cefepime and other broad-spectrum β-lactamas against bacteria from Indonesian medical centers. Diagn Microbiol Infect Dis. 35:1999;285-290.
6. Jacoby G.A., Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol. 34:1996;908-911.
7. Jones R.N., Baquero F., Privitera G., Inoue M., Wiedemann B. Inducible β-lactamase-mediated resistances to third-generation cephalosporins. Clin Microbiol Infect. 3:(suppl 1):1997;S7-S20.
8. Jones R.N., Pfaller M.A., Doern G.V., Erwin M.E., Hollis R.J. Antimicrobial activity and spectrum investigation of 8 broad-spectrum β-lactam drugs a 1997 surveillance trial in 102 medical centers in the Untied States . Clin Infect Dis. 30:1997;215-228.
9. Kessler R.E., Fung-Tomc J. Susceptibility of bacterial isolates to β-lactam antibiotics from U.S. clinical trials over a 5-year period. Am J Med. 100:(suppl 6A):1996;13S-19S.
10. Lewis M.T., Biedenbach D.J., Jones R.N. In vitro evaluation of broad-spectrum β-lactams tested in medical centers in Korea role of fourth-generation cephalosporins . Diagn Microbiol Infect Dis. 35:1999;317-323.
11. Lewis M.T., Yamaguchi K., Biedenbach D.J., Jones R.N. In vitro evaluation of cefepime and other broad-spectrum β-lactams in 22 medical centers in Japan a Phase II trial comparing two annual organism samples . Diagn Microbiol Infect Dis (this issue). 1999.
12. Biedenbach E.J., Lewis M.T., Jones R.N. In vitro evaluation of cefepime and other broad-spectrum β-lactams for isolates in Malaysia and Singapore medical centers. Diagn Microbiol Infect Dis. 35:1999;277-283.
13. National Committee for Clinical Laboratory Standards (NCCLS) (1997). Methods for Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically. Approved Standard M7-A4. Wayne, PA: NCCLS.
14. National Committee for Clinical Laboratory Standards (NCCLS) (1999). Performance Standards for Antimicrobial Susceptibility Testing: 9th Informational Supplement M100-S9. Wayne, PA: NCCLS.
15. Johnson D.M., Biedenbach D.J., Jones R.N. In vitro evaluation of broad-spectrum β-lactamas in the Philippines medical centers role of fourth-generation cephalosporins . Diagn Microbiol Infect Dis. 35:1999;291-297.
16. Doern G.V., Jones R.N., Pfaller M.A., Erwin M.E., Ramirez-Rhonda C. Multicenter evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents in Puerto Rico. Diagn Microbiol Infect Dis. 30:1998;113-119.
17. Sader H.S., Mimica I., Rossi F., Zoccoli C., Montelli A.C., Sampaio J.L.M., Segura A.J.A., Magalhaes M., Nowakonski A., Mendes C.M.F. Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from eighteen Brazilian hospitals by using the Etest. Diagn Microbiol Infect Dis. 28:1997;87-92.
18. Sanders W.E., Tenney J.H., Kessler R.E. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter spp. Clin Infect Dis. 23:1996;454-461.
19. IMP) in Gram-negative rods resistant to broad-spectrum β-lactams. J Clin Microbiol. 34:1996;2909-2913.
20. Biedenbach D.J., Johnson D.M., Jones R.N. In vitro evaluation of cefepime and other broad-spectrum β-lactams in Taiwan medical centers. Diagn Microbiol Infect Dis. 35:1999;299-305.
21. Biedenbach D.J., Johnson D.M., Jones R.N. In vitro evaluation of cefepime and other broad-spectrum β-lactams in eight medical centers in Thailand. Diagn Microbiol Infect Dis. 35:1999;325-331.
22. Thauvin-Eliopoulos C., Tripodi M.F., Moellering R.C. Jr, Eliopoulos G.M. Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum β-lactamase-producing strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 41:1997;1053-1057.
23. Pfaller M.A., Korten V., Jones R.N., Doern G.V. Multicenter evaluation of the antimicrobial activity for seven broad-spectrum β-lactams in Turkey using the Etest method. Diagn Microbiol Infect Dis. 35:1999;65-73.
24. Pfaller M.A., Jones R.N., Doern G.V. Multi-center evaluation of the antimicrobial activity for six broad-spectrum β-lactams in Venezuela by using the Etest method. Diagn Microbiol Infect Dis. 30:1998;45-52.
25. Xu Y., Chen M., Biedenbach D.J., Deshpande L.M., Jones R.N. Evaluation of the in vitro antimicrobial activity of cefepime compared to other broad-spectrum βlactams tested against recent clinical isolates from 10 Chinese hospitals. Diagn Microbiol Infect Dis. 35:1999;135-142.